ISSN: 2228-5881 eISSN: 2251-7308

Submit Your Paper Instructions for Authors Aims and Scope Editorial Board Editorial Policies Publication Ethics Indexing Info About APB & Contacts Indexing and Abstracting Articles In Press Archive

Journal Info:

Freq.: Quarterly

eISSN: 2251-7308
pISSN: 2228-5881

Permission: CC By

Platinum Open Access

(no submission or publication fees)

Abstracting and Indexing

PubMed Central, Pubmed,

Emerging Sources Citation Index

Scopus, Google Scholar,

EMBASE/Excerpta Medica

EBSCOhost; CAS: DOAJ

2025, Vol 15, No. 1

Advanced Pharmaceutical Bulletin (APB) is a peer-reviewed multidisciplinary open access journal, covering a wide range of various integrative fields with Pharmaceutical sciences.
APB is the official journal of Drug Applied Research Center and Faculty of Pharmacy, published by TUOMS PRESS, Tabriz University of Medical Sciences.

Publication Advantages in Advanced Pharmaceutical Bulletin are:

Free of charge publication for all types of articles
Fast and constructive peer review
Easy and quick online submission of manuscripts
Author friendly review
Rapid publication by means of running issue concept, which gives authors the benefit of 'No Waiting Time' for the officially accepted manuscripts
Free publication of color images
Worldwide visibility of papers (Open Access Journal)

Original Research

1. In Silico Analysis of HA2/Mx Chimera Peptide for Developing an Adjuvanted Vaccine to Induce Immune Responses Against Influenza Viruses

Sina Soleimani, Omid Madadgar, Shahla Shahsavandi*, Homayoon Mahravani, Mohsen Lotfi

Adv Pharm Bull. 2015;5(5): 629-636. doi: 10.15171/apb.2015.085

PMCID: PMC4708033 PMID: 26793608 Scopus ID: 84941552730

Article

PDF

XML

Cited By:

Research Article

2. Evaluation of Immunogenic Effect of Toxoplasma gondii Recombinant SAG-1 Antigen with Propranolol as Adjuvant in BALB/c Mice

Esmaeil Abasi , Shahram Shahabi , Majid Golkar , Peyman Khezri , Habib Mohammadzadeh Hajipirloo*

Adv Pharm Bull. 2019;9(4): 632-639. doi: 10.15171/apb.2019.073

PMCID: PMC6912185 PMID: 31857968 Scopus ID: 85075825922

Article

PDF

XML

Cited By:

Research Article

3. Evaluation of Adjuvant Effectiveness of Alum-Propranolol Mixture on the Immunogenicity of Excreted/Secreted Antigens of Toxoplasma gondii RH Strain

Elyar Meshkini , Arash Aminpour* , Khosrow Hazrati Tappeh, Shahram Seyyedi, Meysam Shokri

Adv Pharm Bull. 2021;11(3): 570-577. doi: 10.34172/apb.2021.066

PMCID: PMC8421635 PMID: 34513633 Scopus ID: 85108908185

Article

PDF

Full Text

XML

Cited By:

Review Article

4. mRNA as a Therapeutics: Understanding mRNA Vaccines

Ferdi Oğuz , Harika Atmaca*

Adv Pharm Bull. 2022;12(2): 274-282. doi: 10.34172/apb.2022.028

PMCID: PMC9106950 PMID: 35620336 Scopus ID: 85128230280

Article

PDF

Full Text

XML

Cited By:

Review Article

5. Recent Update of COVID-19 Vaccines

Sameer A. Jadaan* , Abdul Waheed Khan

Adv Pharm Bull. 2022;12(2): 219-236. doi: 10.34172/apb.2022.045

PMCID: PMC9106961 PMID: 35620327 Scopus ID: 85128147762

Article

PDF

Full Text

XML

Cited By:

Editorial

6. Recent Updates in Vaccine Delivery through Microneedles

Kasturi Pawar*

Adv Pharm Bull. 2023;13(1): 1-4. doi: 10.34172/apb.2023.001

PMCID: PMC9871281 PMID: 36721802

Article

PDF

Full Text

XML

Cited By:

Systematic Review

7. ChAdOx1 nCoV-19 Vaccine and Thrombosis with Thrombocytopenia Syndrome among Adults: A Systematic Review

Homa Faghihi , Negar Mottaghi-Dastjerdi* , Mohammad Sharifzadeh, Nader Rahimi Kakavandi

Adv Pharm Bull. 2023;13(4): 723-735. doi: 10.34172/apb.2023.081

PMCID: PMC10676559 PMID: 38022808

Article

PDF

Suppl 1

Full Text

XML

Cited By:

Review Article

8. Nanovaccines against Cervical Cancer: Reliable Strategies to Circumvent Limitations of Traditional Therapeutic Vaccines

Enwa Felix Oghenemaro , Safia Obaidur Rab, Ebraheem Abdu Musad Saleh* , Asmaa F. Kassem, Jasur Rizaev, Deepak Nathiya, Parjinder Kaur, M. Ravi Kumar, Karam Kadhim, Ahmed M. Hashim

Adv Pharm Bull. 2025;15(1): 46-59. doi: 10.34172/apb.43712

Article

PDF

XML

Cited By: